The TauTona Group

TauTona Group is a vertically integrated operational fund that creates, invests, and develops new solutions in medtech, biotech, and regenerative medicine that address unmet clinical needs in healthcare. With a strong belief that improvements in healthcare and cost reductions can only be achieved through innovation, TauTona’s sustainable investment model enables disruptive ideas to be evaluated, designed, tested, and developed in an extremely economical manner, benefiting all stakeholders: inventors, investors, doctors, and, most importantly, patients. The fund was founded in 2010 by two Stanford School of Medicine professors and researchers focused on bioengineering, tissue regeneration, and stem cell therapeutic approaches. People World-class team of doctors, researchers, engineers, and entrepreneurs who have built several companies and medical devices. Products Valuable pipeline of leading-edge medtech, biotech, and regenmed products that have the ability to enhance R&D and optimize portfolios for leading healthcare companies. Process Differentiated development process designed to de-risk projects from ideation to commercialization to optimize medical impact and financial returns. Philosophy TauTona’s contrarian approach provides the ideal investment platform to accelerate the development of medical devices.